{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:39:38Z","timestamp":1775147978983,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["TTK14052268878"],"award-info":[{"award-number":["TTK14052268878"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010345"],"award-info":[{"award-number":["D43-TW010345"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010543"],"award-info":[{"award-number":["D43-TW010543"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["TTK14052268878"],"award-info":[{"award-number":["TTK14052268878"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43-TW010345"],"award-info":[{"award-number":["D43-TW010345"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43-TW010543"],"award-info":[{"award-number":["D43-TW010543"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002806","name":"Discovery Eye Foundation","doi-asserted-by":"publisher","award":["TTK14052268878"],"award-info":[{"award-number":["TTK14052268878"]}],"id":[{"id":"10.13039\/100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002806","name":"Discovery Eye Foundation","doi-asserted-by":"publisher","award":["D43-TW010345"],"award-info":[{"award-number":["D43-TW010345"]}],"id":[{"id":"10.13039\/100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002806","name":"Discovery Eye Foundation","doi-asserted-by":"publisher","award":["D43-TW010543"],"award-info":[{"award-number":["D43-TW010543"]}],"id":[{"id":"10.13039\/100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TTK14052268878"],"award-info":[{"award-number":["TTK14052268878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010345"],"award-info":[{"award-number":["D43-TW010345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010543"],"award-info":[{"award-number":["D43-TW010543"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pathol.2020.11.004","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T22:29:35Z","timestamp":1612650575000},"page":"628-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-5504","authenticated-orcid":false,"given":"Katherine","family":"Antel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Oosthuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Van der Vyver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.11.004_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2020.11.004_bib2","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12885-019-5586-4","article-title":"The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting","volume":"19","author":"Antel","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pathol.2020.11.004_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00277-018-3533-0","article-title":"Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration","volume":"98","author":"Swart","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2020.11.004_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","article-title":"Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)","volume":"31","author":"Gordon","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3324\/haematol.2011.055459","article-title":"Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin\u2019s lymphoma","volume":"97","author":"Sanchez-Espiridion","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2020.11.004_bib7","first-page":"2183","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\u2019s lymphoma","volume":"30","author":"Younes","year":"2012","journal-title":"Soc Hematol"},{"key":"10.1016\/j.pathol.2020.11.004_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2020.11.004_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin\u2019s lymphoma microenvironment and its role","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hon.2295","article-title":"Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin\u2019s lymphoma","volume":"35","author":"Gotti","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2011.39.9881","article-title":"Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical hodgkin lymphoma is predictive of outcome","volume":"31","author":"Greaves","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3324\/haematol.2010.031542","article-title":"Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin\u2019s lymphoma","volume":"96","author":"Kamper","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2020.11.004_bib13","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2020.11.004_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3109\/10428194.2013.824079","article-title":"CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma","volume":"55","author":"Kayal","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2020.11.004_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10428199509054433","article-title":"Human immunodeficiency virus associated hodgkin\u2019s disease: report of 45 cases from the French registry of HIV-associated tumors","volume":"16","author":"L\u00e9vy","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2020.11.004_bib17","first-page":"2319","article-title":"Human immunodeficiency virus-associated Hodgkin\u2019s disease derives from post-germinal center B cells","volume":"93","author":"Carbone","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib18","first-page":"1073","article-title":"High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin\u2019s disease","volume":"142","author":"Herndier","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/modpathol.2012.217","article-title":"Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma","volume":"26","author":"Hartmann","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-005-1051-3","article-title":"Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin\u2019s lymphoma","volume":"84","author":"Bosch Pr\u00edncep","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2020.11.004_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1440-1827.2011.02754.x","article-title":"FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma","volume":"62","author":"Kiyasu","year":"2012","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2020.11.004_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/his.12458","article-title":"The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma","volume":"65","author":"Koulis","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.11.004_bib23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib24","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib25","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2020.11.004_bib27","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano Classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A\u00a0prognostic score for advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2020.11.004_bib29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2020.11.004_bib31","series-title":"Version 10.1","year":"2008"},{"key":"10.1016\/j.pathol.2020.11.004_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.1711670406","article-title":"Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin\u2019s disease in HIV-positive patients","volume":"167","author":"Audouin","year":"1992","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12957-017-1147-y","article-title":"Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters","volume":"15","author":"Hashmi","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib34","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V94.2.442.414a46_442_447","article-title":"Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin\u2019s disease","volume":"94","author":"Murray","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.004_bib36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1054\/bjoc.2001.1774","article-title":"Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin\u2019s disease","volume":"84","author":"Glavina-Durdov","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2020.11.004_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428190009113386","article-title":"Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin\u2019s disease treated with chemotherapy","volume":"39","author":"Montalban","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2020.11.004_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.MP.0000071843.09960.BF","article-title":"Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin\u2019s lymphoma: a single-institution study","volume":"16","author":"Krugmann","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/1097-0142(20010415)91:8<1579::AID-CNCR1169>3.0.CO;2-L","article-title":"Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women","volume":"91","author":"Clarke","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.11.004_bib40","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","article-title":"Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin\u2019s lymphoma predicts adverse outcome in older adult patients","volume":"27","author":"Diepstra","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9896(199704)181:4<353::AID-PATH782>3.0.CO;2-3","article-title":"Epstein-barr virus in Hodgkin's disease: more than just an innocent bystander","volume":"181","author":"Oudejans","year":"1997","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2141.2002.03815.x","article-title":"Hodgkin\u2019s disease in the elderly: a population-based study","volume":"119","author":"Stark","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2020.11.004_bib43","first-page":"2114","article-title":"Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome","volume":"9","author":"Herling","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2020.11.004_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ajcp\/98.3.319","article-title":"Influence of Epstein-Barr virus genomes on patient survival in Hodgkin\u2019s disease","volume":"98","author":"Fellbaum","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2020.11.004_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/028418699431942","article-title":"Epstein-Barr virus distribution in Hodgkin\u2019s disease in an unselected Swedish population","volume":"38","author":"Enblad","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1016\/j.pathol.2020.11.004_bib46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ijc.2910500432","article-title":"Prognosis of Hodgkin\u2019s disease in not influenced by Epstein-Barr virus latent membrane protein","volume":"50","author":"Vestlev","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2020.11.004_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jiac.2016.09.004","article-title":"Prognostic significance of Epstein\u2013Barr virus (EBV) infection in Hodgkin lymphoma patients","volume":"23","author":"Myriam","year":"2017","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:17:05Z","timestamp":1626344225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0031302521000234"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.11.004","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}